Enzyme Studies in Cerebral Tumours
Author Information
Author(s): Monamy Buckell, May C. Robertson
Primary Institution: Neurosurgical Research Laboratories, Atkinson Morley's Hospital, London
Hypothesis
Higher enzyme content in cyst fluids from secondary carcinomas may aid in differential diagnosis of brain tumors.
Conclusion
Lactate dehydrogenase levels in cyst fluids correlate with the degree of malignancy in brain tumors, but this is not reflected in plasma or cerebrospinal fluid.
Supporting Evidence
- Mean plasma LDH was 235 i.u. for glioma patients and 219 i.u. for secondary carcinoma patients.
- LDH activity was present in measurable amounts in six of eight control specimens of ventricular CSF.
- 95% of glioma patients had increased plasma glucose phosphate isomerase.
- LDH levels in cyst fluids were significantly higher than in plasma for both glioma and secondary carcinoma cases.
Takeaway
Doctors looked at fluids from brain tumors to see if certain enzymes could help tell if a tumor is more or less serious. They found that one enzyme, lactate dehydrogenase, was higher in more serious tumors.
Methodology
Cyst fluid was collected during surgery, and enzyme activities were measured in plasma, cerebrospinal fluid, and cyst fluid using colorimetric methods.
Limitations
The study did not establish a clear biochemical distinction between primary and metastatic brain tumors.
Participant Demographics
21 cases with glioma and 16 cases with cerebral secondary carcinoma.
Want to read the original?
Access the complete publication on the publisher's website